Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2695

Actual shortage: 246 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2440 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2024-01-08 194191
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195763
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-07 2024-05-09 221546
TEVA-METHYLPHENIDATE ER-C 36MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-11-24 2020-01-21 30688
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
TEVA-TRAMADOL/ACETAMINOPHEN 37.5MG 325MG TABLET Resolved 2019-10-24 2020-09-03 97150
TEVA-TRAMADOL/ACETAMINOPHEN 37.5MG 325MG TABLET Resolved 2022-04-21 2022-08-19 159213
TEVA-TRAMADOL/ACETAMINOPHEN 37.5MG 325MG TABLET Resolved 2023-02-02 2023-06-09 183407
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92666
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2020-05-01 2020-06-11 113803
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-03-26 2020-05-08 109583
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-09-24 2020-10-22 124986
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-12-02 2022-02-10 150403
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176794
TEVA-NAPROXEN 375MG TABLET Resolved 2023-11-09 2024-01-11 209661
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2024-01-11 2024-03-18 215719
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 3G 0.375G POWDER FOR SOLUTION Resolved 2017-03-13 2018-03-01 1811
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 3G 0.375G POWDER FOR SOLUTION Resolved 2020-04-10 2023-10-04 111877
TEVA-BROMAZEPAM 3MG TABLET Resolved 2020-01-17 2020-02-07 103552
TEVA-BROMAZEPAM 3MG TABLET Resolved 2020-05-01 2020-05-08 113732

Showing 1901 to 1920 of 2695

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 250